{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:30:35Z","timestamp":1793298635836,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-18-0022147"],"award-info":[{"award-number":["G-18-0022147"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jacl.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:22:35Z","timestamp":1588825355000},"page":"398-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association"],"prefix":"10.1016","volume":"14","author":[{"given":"Emily E.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Barton","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Underberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2020.04.011_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"6 Suppl","key":"10.1016\/j.jacl.2020.04.011_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"3 Suppl","key":"10.1016\/j.jacl.2020.04.011_bib3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"13","key":"10.1016\/j.jacl.2020.04.011_bib4","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further Evolution of the ACC\/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jacl.2020.04.011_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000482","article-title":"Polygenic influences on dyslipidemias","volume":"29","author":"Dron","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2020.04.011_bib8","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacl.2020.04.011_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/L17-0182","article-title":"Polygenic risk for hypertriglyceridemia can mimic a major monogenic mutation","volume":"167","author":"Stahel","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2020.04.011_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000576","article-title":"The evolution of genetic-based risk scores for lipids and cardiovascular disease","volume":"30","author":"Dron","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2020.04.011_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2020.04.011_bib15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.04.011_bib16","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1194\/jlr.M079822","article-title":"Polygenic determinants in extremes of high-density lipoprotein cholesterol","volume":"58","author":"Dron","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.04.011_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib19","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2020.04.011_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The Chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia--current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2020.04.011_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pathol.2018.10.014","article-title":"The role of genetic testing in dyslipidaemia","volume":"51","author":"Berberich","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.jacl.2020.04.011_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOL.0000000000000192","article-title":"Dysbetalipoproteinemia: an extreme disorder of remnant metabolism","volume":"26","author":"Marais","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOL.0000000000000590","article-title":"The biochemical and genetic diagnosis of lipid disorders","volume":"30","author":"Schaefer","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib26","series-title":"GeneReviews(R)","article-title":"Abetalipoproteinemia","author":"Burnett","year":"1993"},{"key":"10.1016\/j.jacl.2020.04.011_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacl.2017.04.116","article-title":"Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences","volume":"11","author":"Tzavella","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2020.04.011_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcad.2016.08.006","article-title":"Diagnosis and treatment of high density lipoprotein deficiency","volume":"59","author":"Schaefer","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2020.04.011_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12920-020-0669-2","article-title":"Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias","volume":"13","author":"Dron","year":"2020","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacl.2020.04.011_bib31","first-page":"57266","article-title":"Targeted next-generation sequencing and bioinformatics pipeline to evaluate genetic determinants of constitutional disease","author":"Dilliott","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jacl.2020.04.011_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MOL.0000000000000579","article-title":"Editorial: designing targeted sequencing panels for dyslipidemia","volume":"30","author":"Hegele","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamacardio.2017.2352","article-title":"Role of genetic testing in inherited cardiovascular disease: a review","volume":"2","author":"Cirino","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/humu.20105","article-title":"LDL-receptor mutations in Europe","volume":"24","author":"Dedoussis","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2020.04.011_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia","volume":"35","author":"Rios","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2020.04.011_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOL.0000000000000483","article-title":"Role of DNA copy number variation in dyslipidemias","volume":"29","author":"Iacocca","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib38","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/01.AOG.0000292086.98514.8b","article-title":"ASHG Statement on direct-to-consumer genetic testing in the United States","volume":"110","author":"Hudson","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacl.2020.04.011_bib39","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/gim.2018.38","article-title":"False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care","volume":"20","author":"Tandy-Connor","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib40","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib42","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2020.04.011_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2213-8587(19)30156-1","article-title":"Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice","volume":"7","author":"Garg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2020.04.011_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2020.04.011_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2020.04.011_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents","volume":"124","author":"Hegele","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2020.04.011_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.04.011_bib48","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)","volume":"134","author":"Michael Gibson","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2020.04.011_bib49","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.04.011_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/YCO.0b013e3283252d80","article-title":"Psychosocial aspects of genetic testing","volume":"22","author":"Cameron","year":"2009","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jacl.2020.04.011_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMp1404776","article-title":"GINA, genetic discrimination, and genomic medicine","volume":"372","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/507294a","article-title":"Technology: The $1,000 genome","volume":"507","author":"Hayden","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2020.04.011_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/gb-2011-12-8-125","article-title":"The real cost of sequencing: higher than you think!","volume":"12","author":"Sboner","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.jacl.2020.04.011_bib54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/humu.23634","article-title":"ClinVar database of global familial hypercholesterolemia-associated DNA variants","volume":"39","author":"Iacocca","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2020.04.011_bib55","doi-asserted-by":"crossref","first-page":"baz040","DOI":"10.1093\/database\/baz040","article-title":"An enhanced workflow for variant interpretation in UniProtKB\/Swiss-Prot improves consistency and reuse in ClinVar","volume":"2019","author":"Famiglietti","year":"2019","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jacl.2020.04.011_bib56","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41436-018-0432-7","article-title":"A survey assessing adoption of the ACMG-AMP guidelines for interpreting sequence variants and identification of areas for continued improvement","volume":"21","author":"Niehaus","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib57","doi-asserted-by":"crossref","first-page":"103711","DOI":"10.1016\/j.ejmg.2019.103711","article-title":"Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives","volume":"62","author":"Houdayer","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jacl.2020.04.011_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12910-016-0096-2","article-title":"Incidental findings of uncertain significance: To know or not to know--that is not the question","volume":"17","author":"Hofmann","year":"2016","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.jacl.2020.04.011_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jgc4.1098","article-title":"Secondary findings: How did we get here, and where are we going?","volume":"28","author":"Ormond","year":"2019","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jacl.2020.04.011_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2020.04.011_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s40142-014-0036-8","article-title":"The role of genetic counselors for patients with familial hypercholesterolemia","volume":"2","author":"Sturm","year":"2014","journal-title":"Curr Genet Med Rep"},{"key":"10.1016\/j.jacl.2020.04.011_bib62","series-title":"A Guide to Genetic Counseling","author":"Uhlmann","year":"2009"},{"key":"10.1016\/j.jacl.2020.04.011_bib63","series-title":"Psychosocial genetic counseling","author":"Weil","year":"2000"},{"key":"10.1016\/j.jacl.2020.04.011_bib64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","article-title":"Genetic testing in cardiovascular medicine: current landscape and future horizons","volume":"28","author":"Sturm","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib65","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.hrthm.2011.07.017","article-title":"The emerging role of the cardiac genetic counselor","volume":"8","author":"Ingles","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacl.2020.04.011_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2020.04.011_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajmg.a.32672","article-title":"Family letters are an effective way to inform relatives about inherited cardiac disease","volume":"149A","author":"van der Roest","year":"2009","journal-title":"Am J Med Genet A"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420300817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420300817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:35:36Z","timestamp":1761831336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287420300817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1933287420300817"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2020.04.011","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}